Box Office: 'Old' Creeps Over 'Snake Eyes' with $16.5M

The Weekend's Top 3 Box Office Winners: M. Night Shyamalan's "Old" - $16.5M; "Snake Eyes: G.I. Joe Origins" - $13.4M; "Black Widow" - $11.6M.

Matt Lissauer

By Matt Lissauer

Box Office - Vicky Krieps and Thomasin McKenzie in "Old."

© Universal Pictures / Courtesy Everett Collection

It was a neck and neck race, but Universal's "Old" took the box office crown over Paramount's "Snake Eyes," which by the looks of its reception ended up rolling exactly that. Analysts gave the G.I. Joe prequel an edge over M. Night Shyamalan's latest thriller, but it failed to live up to expectations both critically and financially. "Old" claimed $16.5M overall. While this may be Shyamalan's lowest opening weekend to date, the thriller still managed to head off, not just the expected box office winner, but also last week's champion, "Space Jam: A New Legacy," which fell 69% and only took in $9.7M, placing it at number four.

"Old" may not have made as much as Shyamalan's previous outings, 2016's "Split" and 2019's "Glass," but its low-budget price tag (made for $18M) means that the film will still turn a profit in spite of its muted performance. The thriller also stands as Shyamalan's seventh film to open at number one.

© Paramount / Courtesy Everett Collection

© Paramount / Courtesy Everett Collection

Unlike the last two box office winners, "Old" and "Snake Eyes" were theatrical exclusives. Their failures to generate the gains the recovering box office has seen as of late, has more to do with the films themselves than any at-home take cutting into box office performance. Though adapted from a source novel, "Old" is largely an original story not based on any pre-existing I.P. Paramount's "Snake Eyes," on the other hand, was the studio's second attempt to reboot a wearying franchise that is only comprised two other films. COVID concerns over the Delta variant were likely another factor contributing to the low take, but, this would have been a low-earning weekend even in normal times.

"Black Widow" posted $11.6M, placing it at number three and bringing its overall gross to $154.8M. While not nearly as big as previous Marvel films in their third week, it's still a decent take in the middle of a pandemic. The bigger news is the airball "Space Jam 2" suffered in its second week. Middling reviews, combined with its simultaneous release on HBO Max, is a large factor here. "A New Legacy" will likely not live up to the footprint forged by its predecessor.

"F9" rounded out the Top Five, with $4.7M, and holdovers held steady among the top ten. While this weekend might have missed expectations, next weekend shows promise with Disney's big adventure "Jungle Cruise," starring Dwayne Johnson and Emily Blunt. And on the indie side, a few anticipated films are being released including A24's medieval actioner "The Green Knight," Matt Damon's recent Cannes hit "Stillwater," and the long-delayed 2020 Sundance gem "Nine Days."

Box Office Top Ten: July 23-25

  1. "Old" (Universal) - $16,510,000 [NEW]
  2. "Snake Eyes" (Paramount) - $13,350,000 [NEW]
  3. "Black Widow" (Disney) - $11,600,000 / Overall: $154,806,683
  4. "Space Jam: A New Legacy" (WB) - $9,560,000 / Overall: $51,367,605
  5. "F9" (Universal) - $4,700,000 / Overall: $163,396,825
  6. "Escape Room: Tournament of Champions" (Sony) - $3,400,000 / Overall: $16,048,270
  7. "The Boss Baby: Family Business" (Universal) - $2,700,000 / Overall: $50,132,635
  8. "The Forever Purge" (Universal) - $2,300,000 / Overall: $40,306,710
  9. "A Quiet Place: Part II" (Paramount) - $1,250,000 / Overall: $157,523,623
  10. "Roadrunner" (Focus Features) $830,000 / Overall: $3,701,480

Box office data comes to us from Box Office Mojo.

Matt Lissauer

Matt Lissauer is a writer & data manager for Noovie. When he is not busy writing listicles, Matt is enjoying life in New Jersey with his lovely wife and three kids.

More from Matt Lissauer

Be the First to Know.

Get articles like this and the latest movie news in your inbox.

Subscribing to a newsletter indicates your consent to our Terms of Use and Privacy Policy. You may unsubscribe from the newsletters at any time.